CLINICAL TRIAL: TONIC - TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN

临床试验：补品 - 治疗儿童非酒精性脂肪性肝炎

• 批准号: 7724926
• 负责人: JOEL Edward LAVINE
• 金额: $ 14.98万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-12-01 至 2008-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7724926
• 关键词: Child; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Institution; Metformin; Placebos; Research; Research Personnel; Resources; Serum; Source; United States National Institutes of Health; Vitamin E; Week; non-alcoholic fatty liver; non-diabetic; nonalcoholic steatohepatitis

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Evaluate whether 96 weeks of treatment with either metformin or vitamin E leads to sustained reduction in serum ALT in nondiabetic children with NAFLD compared to treatment with placebo.

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 评估与安慰剂治疗相比，二甲双胍或维生素E治疗96周是否导致患有NAFLD的非糖尿病儿童血清ALT持续降低。